A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : TRL / tacrolimus

[Related PubMed/MEDLINE]
Total Number of Papers: 37
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   TRL  (>> Co-occurring Abbreviation)
Long Form:   tacrolimus
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2018 Posaconazole Tablets in Real-Life Lung Transplantation: Impact on Exposure, Drug-Drug Interactions, and Drug Management in Lung Transplant Patients, Including Those with Cystic Fibrosis. CF, CFLT patients, ERL, LT, NCFLT patients, NT, OSF, PPI, PSZ
2012 Combined introduction of anti-IL2 receptor antibodies, mycophenolic acid and tacrolimus: effect on malignancies after renal transplantation in a single-centre retrospective cohort study. AZA, CI, IL-2RA, MPA, PTLD
2012 Immunophyllin ligands show differential effects on alcohol self-administration in C57BL mice. CLN, CsA, SRL
2012 Simultaneous determination of cyclosporine A, tacrolimus, sirolimus, and everolimus in whole-blood samples by LC-MS/MS. CyA, MRM, SIR
2011 Frontiers in immunosuppression. CTLA-4, JAK, PKC
2011 Regulatory mechanisms of calcineurin phosphatase activity. CsA
2011 Therapeutic drug monitoring in de novo kidney transplant receiving the modified-release once-daily tacrolimus. AUC, AVF, PGF, TDM
2010 Cytomegalovirus infection after liver transplantation: prophylaxis and preemptive treatment--a single-center experience. CMV, HBV, HCV
2010 Sublingual tacrolimus as an alternative to intravenous route in patients with thoracic transplant: a retrospective study. AUC, i.v, SL
10  2010 Toward personalized medicine in renal transplantation. ---
11  2009 Explaining variability in tacrolimus pharmacokinetics to optimize early exposure in adult kidney transplant recipients. ---
12  2009 Safe management of tacrolimus together with posaconazole in lung transplant patients with cystic fibrosis. PSZ
13  2008 Calcineurin activity and inhibition in skin and (epi)dermal cell cultures. CN, CsA, Prl
14  2008 Conversion from tacrolimus to cyclosporine A for new-onset diabetes after transplantation: a single-centre experience in renal transplanted patients and review of the literature. CsA, NODAT
15  2008 Effects of cyclosporine, tacrolimus and sirolimus on vascular changes related to immune response. DSA, SRL
16  2008 Impact of changing from cyclosporine to tacrolimus on pharmacokinetics of mycophenolic acid in renal transplant recipients with diabetes. MMF, MPA
17  2007 Pharmacodynamics of T-cell function for monitoring immunosuppression. CsA, PCNA, PD, SRL
18  2006 Effect of atorvastatin therapy and conversion to tacrolimus on hypercholesterolemia and endothelial dysfunction after renal transplantation. CsA, FMD, HDL, LDL
19  2006 Influence of methylprednisolone on plasma homocysteine levels in cadaveric renal transplant recipients. MMF, MP, tHcy
20  2006 Neuroendocrine-immune modulation may be useful for allograft-specific immunosuppression in small bowel transplantation. BBS, SBT
21  2006 Novel apoptosis assay to analyze immunosuppression. CsA, MPA, RAPA
22  2006 Role of FK778 alone or in combination with tacrolimus or mTOR inhibitors as an immunomodulator of immunofunctions: in vitro evaluation of T cell proliferation and the expression of lymphocyte surface antigens. EVL, MPA, SRL
23  2006 The effect of MDR1 (ABCB1) polymorphism on the pharmacokinetic of tacrolimus in Turkish renal transplant recipients. MDR1, P-gp, SNP
24  2006 The influence of immunosuppressive drugs on T- and B-cell apoptosis via p53-mediated pathway in vitro and in vivo. MPA
25  2006 Transplantation of preconditioned intestinal grafts is associated with lower inflammatory activation and remote organ injury in rats. ---
26  2005 Low hematocrit and serum albumin concentrations underlie the overestimation of tacrolimus concentrations by microparticle enzyme immunoassay versus liquid chromatography-tandem mass spectrometry. MEIA
27  2005 Mycophenolic acid interaction with cyclosporine and tacrolimus in vitro and in vivo: evaluation of additive effects on rat blood lymphocyte function. MMF, MPA
28  2005 Pharmacodynamic monitoring of the conversion of cyclosporine to tacrolimus in heart and lung transplant recipients. MPA, PD
29  2004 Experimental limb transplantation, part I: identification of an effective tapered triple combination immunosuppressive regime. MMF, PRED
30  2004 Experimental limb transplantation, part II: excellent return of function and indefinite survival after withdrawal of immunosuppression. MMF
31  2004 In vitro evaluation of the effects of candidate immunosuppressive drugs: flow cytometry and quantitative real-time PCR as two independent and correlated read-outs. CsA
32  2004 Simultaneous determination of four immunosuppressants by means of high speed and robust on-line solid phase extraction-high performance liquid chromatography-tandem mass spectrometry. CyA, MRM, SRL, TDM
33  2004 Synergistic effects of sirolimus with cyclosporine and tacrolimus: analysis of immunosuppression on lymphocyte proliferation and activation in rat whole blood. LC-MS, PCNA, PD, PK, SRL
34  2003 Assessment of immunosuppressive drug interactions: inhibition of lymphocyte function in peripheral human blood. MMF, PCNA, SRL
35  2003 Pharmacodynamic approach to immunosuppressive therapies using calcineurin inhibitors and mycophenolate mofetil. AP, CNA, CNIs, IL-2, MMF
36  2002 Review: metabolism of immunosuppressant drugs. AUC, MMF, MPA, SRL, TDM
37  2001 Comparison of the effects of tacrolimus and cyclosporine on the pharmacokinetics of mycophenolic acid. MMF, MPA, PK